Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration

References

• Ahsan F, Rivas IP, Khan MA, et al. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Control Release 79:29–40.
   PubMed Web of Science ®Google Scholar
• Allen TM, Hansen CB, Guo LS. (1993). Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim Biophys Acta 1150:9–16.
   PubMed Web of Science ®Google Scholar
• Casley-Smith JR. (1980). The fine structure and functioning of tissue channels and lymphatics. Lymphology 13:177.
   PubMed Web of Science ®Google Scholar
• Cox PH. (1981). The kinetics of macromolecule transport in lymph and colloid accumulation in lyirphnodes. Prog Neuropsychopharmacol Biol Psychiatry 2:267–92.
   Google Scholar
• Cohen MS, Cai S, Xie Y, Forrest ML. (2009). A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo. Am J Surg 198:781–6.
   PubMedGoogle Scholar
• Cai S, Yang Q, Bagby TR, Forrest ML. (2011). Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Adv Drug Deliv Rev 63:901.
   PubMed Web of Science ®Google Scholar
• Chen Z, Gong X, Yang L, et al. (2014). Enhancing effect of borneol and muscone on geniposide transport across the human nasal epithelial cell monolayer. Plos One 9:e101414.
   PubMed Web of Science ®Google Scholar
• Duan M, Xing Y, Guo J, et al. (2016). Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins. Pharm Biol 54:3009–10.
   PubMed Web of Science ®Google Scholar
• Hawley AE, Davis SS, Illum L. (1995). Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Adv Drug Deliv Rev 17:129–48.
   Web of Science ®Google Scholar
• Lu Y, Du S, Bai J, et al. (2012). Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice. Int J Mol Sci 13:14127.
   PubMed Web of Science ®Google Scholar
• Mai LM, Lin CY, Chen CY, Tsai YC. (2003). Synergistic effect of bismuth subgallate and borneol, the major components of Sulbogin, on the healing of skin wound. Biomaterials 24:3005–12.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Moghimi M. (2008). Enhanced lymph node retention of subcutaneously injected IgG1-PEG2000-liposomes through pentameric IgM antibody-mediated vesicular aggregation. Biochim Biophys Acta 1778:51–5.
   PubMed Web of Science ®Google Scholar
• Mcallaster JD, Cohen MS. (2011). Role of the lymphatics in cancer metastasis and chemotherapy applications. Adv Drug Deliv Rev 63:867–75.
   PubMed Web of Science ®Google Scholar
• Oussoren C, Zuidema J, Crommelin DJA, Storm G. (1997). Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. ii. Influence of liposomal size, lipid composition and lipid dose. Biochim Biophys Acta 1328:261–72.
   PubMed Web of Science ®Google Scholar
• Ru G, Han L, Qing J, et al. (2016). Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration. Drug Deliv 23:3417.
   PubMed Web of Science ®Google Scholar
• Swartz MA. (2001). The physiology of the lymphatic system. Adv Drug Deliv Rev 50:3–20.
   PubMed Web of Science ®Google Scholar
• Singh I, Swami R, Khan W, Sistla R. (2014). Lymphatic system: a prospective area for advanced targeting of particulate drug carriers. Expert Opin Drug Deliv 11:211–29.
   PubMed Web of Science ®Google Scholar
• Su J, Lai H, Chen J, et al. (2013). Natural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage. Plos One 8:e63502.
   PubMed Web of Science ®Google Scholar
• Tao Y, Tang D, Fan W, et al. (2017). Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. Drug Deliv 24:422.
   PubMed Web of Science ®Google Scholar
• Wang S, Ye T, Yang BS, et al. (2013). 7-Ethyl-10-hydroxycamptothecin proliposomes with a novel preparation method: optimized formulation, characterization and in vivo evaluation. Drug Dev Industr Pharm 39:393.
   PubMed Web of Science ®Google Scholar
• Willis L, Hayes D, Mansour HM. (2012). Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery. Lung 190:251–62.
   PubMed Web of Science ®Google Scholar
• Ye T, Zhang WJ, Sun MS, et al. (2014). Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting. Int J Pharm 471:245–57.
   PubMed Web of Science ®Google Scholar
• Ye T, Jiang X, Li J, R, YG, et al. (2015). Low molecular weight heparin mediating targeting of lymph node metastasis based on nanoliposome and enzyme–substrate interaction. Carbohydr Polym 122:26–38.
   PubMed Web of Science ®Google Scholar
• Yang R, Mao Y, Ye T, et al. (2015). Study on enhanced lymphatic exposure of polyamidoamin-alkali blue dendrimer for paclitaxel delivery and influence of the osmotic pressure on the lymphatic targeting. Drug Deliv 23:1.
   Web of Science ®Google Scholar
• Yi QF, Yan J, Tang SY, et al. (2016). Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids. Drug Dev Industr Pharm 42:1086.
   PubMed Web of Science ®Google Scholar
• Yin Y, Cao L, Ge H, et al. (2017). L-Borneol induces transient opening of the blood-brain barrier and enhances the therapeutic effect of cisplatin. Neuroreport 28:506.
   PubMed Web of Science ®Google Scholar
• Yu XY, Neng PQ, Peng CZ. (2007). The enhancing effect of synthetical borneol on the absorption of tetramethylpyrazine phosphate in mouse. Int J Pharm 337:74–9.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li W, Chen L, et al. (2010). Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitro. Environ Toxicol Pharmacol 29:229–34.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wu D, Wu J, et al. (2015). Improved blood-brain barrier distribution: effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling. J Ethnopharmacol 162:270.
   PubMed Web of Science ®Google Scholar
• Zhang QL, Fu BM, Zhang ZJ. (2017). a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability. Drug Deliv 24:1037.
   PubMed Web of Science ®Google Scholar